Venetoclax Plus CyBorD Induction Therapy and Venetoclax Maintenance Treatment for Immunoglobulin Light Chain Amyloidosis with t(11;14) Translocation. [PDF]
Garami G +7 more
europepmc +1 more source
Gain or amplification of 1q21 in systemic light chain amyloidosis is associated with advanced Mayo stage, plasma cell disease and worse overall survival. [PDF]
Oubari S +13 more
europepmc +1 more source
A Comparative Study of the Electroneurographic Findings in Amyloidotic Polyneuropathy in Patients with Light-Chain Amyloidosis and Glu54Gln Transthyretin Amyloidosis. [PDF]
Drăghici M +7 more
europepmc +1 more source
The clinical trials landscape in immunoglobulin light chain amyloidosis: a systematic review. [PDF]
Ramachandran R +7 more
europepmc +1 more source
Waldenström Macroglobulinemia-Induced Cardiac Amyloid Light Chain Amyloidosis. [PDF]
Fan J +5 more
europepmc +1 more source
Myocardial Characteristics, Cardiac Structure, and Cardiac Function in Systemic Light-Chain Amyloidosis. [PDF]
Clerc OF +14 more
europepmc +1 more source
Early minimal residual disease eradication in light chain amyloidosis generates deeper and faster cardiac response. [PDF]
Xu T +7 more
europepmc +1 more source
Intraoral hemorrhagic bullae as the first sign of immunoglobulin light chain amyloidosis. [PDF]
Dominguez-Lopez RM, Naharro-Rodriguez J.
europepmc +1 more source

